Source | Match | ReputationScore* |
---|---|---|
IDRIS Trial
Collection of samples and data across the following diseases: Plasmacytoma - category (morphologic abnormality) Phase III randomised study of immunomodulatory therapy in high risk solitary bone plasmacytoma.
IDRIS is a randomised, open label, multice
...
|
|
*ReputationScore indicates how established a given datasource is. Find out more.